cancer therapy capsules

Acalieva 100mg Capsule: Next-Generation BTK Inhibition for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Are you searching for a reliable Acalieva 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of highly selective targeted therapies. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical hematology-oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Acalieva 100mg? Acalieva 100mg is an oral targeted therapy containing the active pharmaceutical ingredient Acalabrutinib. Manufactured by Allieva Pharma Pvt Ltd, this 100mg capsule is a second-generation, highly selective Bruton’s Tyrosine Kinase (BTK) inhibitor. It represents a significant advancement in the treatment of B-cell malignancies, offering improved selectivity and a potentially better safety profile compared to first-generation BTK inhibitors. 1. Therapeutic Indications Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): Indicated as a first-line treatment or for patients who have received at least one prior therapy. Mantle Cell Lymphoma (MCL): Used for adult patients who have received at least one prior therapy for their disease. Relapsed or Refractory B-cell Malignancies: Providing a potent oral option for patients whose cancer has returned after initial treatments. 2. Mechanism of Action: Selective BTK Blockade BTK Inhibition: It forms a covalent bond with a cysteine residue (Cys481) in the BTK active site. BTK is a signaling molecule of the B-cell antigen receptor (BCR) pathway. Interrupting Growth Signals: By blocking BTK, Acalieva inhibits the signaling that leads to B-cell proliferation, trafficking, chemotaxis, and adhesion. High Selectivity: As a second-generation inhibitor, it is designed to be more selective for BTK over other kinases (like EGFR or ITK), which helps in reducing off-target side effects. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is 100mg taken orally twice daily (approximately 12 hours apart). Administration: Capsules should be swallowed whole with water. They can be taken with or without food. Acid-Reducing Agents: Patients should exercise caution with Proton Pump Inhibitors (PPIs), as they can affect the absorption of the medication. Consult an oncologist for timing with H2-receptor antagonists or antacids. Clinical Side Effects & Safety Monitoring Hematological Safety: Potential for Cytopenias (anemia, neutropenia, or thrombocytopenia). Periodic Complete Blood Counts (CBC) are necessary. Cardiovascular Health: Monitoring for Atrial Fibrillation and hypertension, though risks may be lower compared to earlier BTK inhibitors. Hemorrhage Risks: Patients should be monitored for signs of bleeding, especially those on concurrent antiplatelet or anticoagulant therapy. Infection Control: Increased susceptibility to opportunistic infections; patients should report any fever or signs of illness immediately. Headache: A common side effect often reported at the start of treatment, which usually subsides over time. Why Source Acalieva 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Acalieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Lenid 10mg Capsule (Lenalidomide): Precision Immunotherapy for Hematological Malignancies Lenid 10mg Capsule is a high-potency anti-cancer medication featuring the active pharmaceutical ingredient Lenalidomide. Classified as an immunomodulatory imide drug (IMiD), Lenid 10mg is a critical therapeutic agent used globally to treat various forms of blood and bone marrow cancers. Manufactured by Natco Pharma Ltd., a global pioneer in oncology generics, Lenid is recognized for its high efficacy in modulating the immune response to identify and destroy malignant cells while inhibiting tumor growth. Therapeutic Indications and Clinical Usage Lenid 10mg is a primary choice in international oncology protocols for: Multiple Myeloma (MM): Indicated for adult patients with newly diagnosed multiple myeloma, often used in combination with dexamethasone. It is also a gold-standard choice for maintenance therapy following autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically used for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma (FL): Used in combination with rituximab for previously treated adult patients with follicular or marginal zone lymphoma. Mechanism of Action: How Lenid 10mg Works Lenid exerts its therapeutic effects through a multi-dimensional biological approach: Immune System Augmentation: It enhances the activity of T-cells and Natural Killer (NK) cells, empowering the body's natural defenses to destroy cancer cells more aggressively. Direct Antitumor Activity: It induces cell cycle arrest and triggers apoptosis (programmed cell death) in malignant hematopoietic cells. Anti-Angiogenesis: It blocks the formation of new blood vessels that tumors rely on for oxygen and nutrients, effectively “starving“ the tumor. Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, which are known to fuel the proliferation of myeloma cells. Dosage and Administration Guidelines Dosing Schedule: Usually administered in 28-day cycles. The 10 mg strength is frequently utilized for maintenance therapy or adjusted dosing based on patient tolerance and renal function. Administration: Capsules must be swallowed whole with water. They should not be opened, crushed, or chewed. Consistency: Can be taken with or without food, but should be taken at approximately the same time each day to maintain steady therapeutic levels. Clinical Monitoring: Dosage adjustments are strictly managed by oncologists based on renal function and blood cell counts. Safety Profile and Side Effect Management As a potent targeted therapy, Lenid 10mg requires vigilant professional oversight: 1. Hematological Vigilance The most common side effects include neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular Complete Blood Counts (CBC) are mandatory to monitor for infection or bleeding risks. 2. Thromboembolism Prophylaxis There is an increased risk of blood clots (DVT or Pulmonary Embolism). Patients are typically prescribed prophylactic anticoagulants (like aspirin or heparin) concurrently. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients of reproductive potential. 4. General Side Effects Commonly reported symptoms include fatigue, diarrhea, muscle cramps, and skin rashes. These are usually managed with supportive care. Storage and Handling Instructions Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Protection: Keep capsules in the original blister packaging to protect from light and moisture. Safety: Caregivers should avoid direct skin contact with the capsules. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Lenmid 25mg Capsule is a high-potency immunomodulatory drug (IMiD) containing the active pharmaceutical ingredient Lenalidomide. It is a cornerstone therapy in modern hematology and oncology, specifically designed to treat various plasma cell dyscrasias and complex blood cancers. Manufactured by Cipla Ltd., a global pharmaceutical leader, Lenmid 25mg is recognized for its high efficacy, safety standards, and role in extending survival rates for patients worldwide. Therapeutic Indications and Clinical Usage Lenalidomide 25 mg is extensively utilized across international oncology protocols for: Multiple Myeloma (MM): Used in combination with dexamethasone for newly diagnosed patients or those who have failed at least one prior therapy. It is also the gold standard for maintenance therapy post-autologous stem cell transplantation (ASCT). Myelodysplastic Syndromes (MDS): Specifically indicated for transfusion-dependent anemia caused by low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after two prior therapies. Follicular & Marginal Zone Lymphoma: Often used in combination with Rituximab for patients previously treated for these indolent lymphomas. Mechanism of Action: How Lenmid 25mg Works Lenmid exerts its anti-cancer effects through a multi-faceted biological approach: Direct Cytotoxicity: It binds to the cereblon E3 ubiquitin ligase complex, leading to the degradation of essential transcription factors, which triggers apoptosis (programmed cell death) in malignant cells. Immune System Enhancement: It stimulates the production of Interleukin-2 (IL-2) and Interferon-gamma (IFN-$gamma$), which enhances the activity of T-cells and Natural Killer (NK) cells to actively destroy tumors. Anti-Angiogenesis: It blocks the secretion of pro-angiogenic factors like VEGF, effectively starving the tumor of the blood supply it needs to grow. Anti-Inflammatory Action: It reduces the production of pro-inflammatory cytokines such as TNF-$alpha$, altering the bone marrow microenvironment to make it less hospitable for cancer cells. Dosage and Administration Guidelines Standard Regimen: Typically administered in 28-day cycles. In multiple myeloma, the standard dose is 25 mg taken orally once daily on Days 1–21, followed by a 7-day break. Method of Intake: Capsules must be swallowed whole with water. They should not be crushed, opened, or chewed. Timing: Can be taken with or without food, but should be taken at the same time every day to maintain consistent blood levels. Renal Monitoring: Since Lenalidomide is primarily excreted by the kidneys, dosage adjustments are vital for patients with impaired renal function. Safety Profile and Side Effect Management Clinical management of Lenmid 25mg involves proactive monitoring of the following: 1. Hematological Support Common side effects include neutropenia (low white blood cells) and thrombocytopenia (low platelets). Regular Complete Blood Counts (CBC) are mandatory. If counts drop significantly, a dose reduction or temporary treatment interruption is standard practice. 2. Thromboembolism Prophylaxis Patients taking Lenmid have an increased risk of venous thromboembolism (blood clots). Standard care involves prescribing prophylactic anticoagulants (like aspirin or heparin) concurrently with the medication. 3. Embryo-Fetal Toxicity (REMS) Lenalidomide is structurally related to thalidomide and is a known teratogen. Strict adherence to pregnancy prevention programs (REMS) is mandatory for all patients of reproductive potential. 4. General Side Effects Patients may report fatigue, diarrhea, muscle cramps, or skin rashes. These are typically managed through adequate hydration, supportive care, and symptomatic medication. Storage and Handling Temperature: Store at room temperature, 20°C to 25°C (68°F to 77°F). Security: Keep in the original blister pack to protect from light and moisture. Handling: Caregivers should handle capsules with care and avoid direct skin contact with the powder inside Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383

Glioz 20mg (Temozolomide) Capsule Glioz 20mg Capsule contains Temozolomide, an oral chemotherapy medicine used in the treatment of certain types of brain tumors. It belongs to the class of medicines known as alkylating agents, which work by damaging the DNA of cancer cells and preventing them from growing and multiplying. Temozolomide capsules are commonly prescribed in oncology treatment protocols and should be taken only under the supervision of a qualified healthcare professional. Ernest Oncology supplies Glioz 20mg (Temozolomide) Capsules globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Glioz Capsule Generic Name: Temozolomide Strength: 20mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Alkylating Agent Packaging Type: Capsule Strip / Bottle Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Glioz 20mg Capsule Glioz (Temozolomide) Capsules are used in the treatment of: • Glioblastoma Multiforme (GBM) • Anaplastic Astrocytoma • Other malignant brain tumors It is often used in combination with radiation therapy or other cancer treatments to improve patient outcomes. How Glioz Capsule Works Temozolomide works by damaging the DNA of cancer cells, preventing them from dividing and multiplying. This helps slow the growth of tumors and supports cancer treatment. Administration Glioz 20mg Capsule should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • On an empty stomach • Swallowed whole with water Dosage and duration depend on the patient’s condition and treatment protocol. Possible Side Effects Some patients may experience: • Nausea and vomiting • Fatigue • Loss of appetite • Constipation • Low blood cell counts • Increased risk of infection Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export oncology medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

Thalidomide 100mg Capsule: Immunomodulatory and Anti-Angiogenic Therapy for Multiple Myeloma and ENL Are you searching for a reliable Thalidomide 100mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted immunomodulatory agents. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Thalidomide 100mg? Thalidomide 100mg is an oral therapeutic agent containing the active pharmaceutical ingredient Thalidomide. Once known primarily for other uses, it has been repurposed as a powerful Immunomodulatory Drug (IMiD). It is a cornerstone in the treatment of plasma cell dyscrasias and specific inflammatory conditions. Due to its potent nature, it is distributed under strict regulatory oversight to ensure patient safety and therapeutic efficacy. 1. Therapeutic Indications Multiple Myeloma: Used in combination with Dexamethasone for patients with newly diagnosed multiple myeloma. It is also utilized in relapsed or refractory cases. Erythema Nodosum Leprosum (ENL): An essential treatment for the cutaneous manifestations of moderate to severe ENL (a complication of leprosy). It is also used as maintenance therapy to prevent and limit the recurrence of skin lesions. Off-Label Oncology Use: Occasionally utilized in research-backed protocols for specific solid tumors and myelodysplastic syndromes where anti-angiogenic properties are required. 2. Mechanism of Action: Multi-Faceted Attack Immunomodulation: It alters the production of cytokines, specifically inhibiting Tumor Necrosis Factor-alpha (TNF-α), which is a key driver of inflammation and cancer cell survival. Anti-Angiogenesis: It blocks the formation of new blood vessels (angiogenesis) by interfering with growth factors like VEGF and bFGF. This effectively “starves“ tumors of the nutrients needed to expand. Direct Anti-Tumor Effect: It induces cell cycle arrest and apoptosis (programmed cell death) in malignant plasma cells by disrupting their interaction with the bone marrow microenvironment. 3. Administration and Dosing Management Standard Dosing: For Multiple Myeloma, the typical dose ranges from 100mg to 200mg daily. For ENL, dosing is adjusted based on the severity of the reaction. Timing: It is generally recommended to take the capsule once daily at bedtime, at least 1 hour after the evening meal, to minimize sedation. Safety Handling: Capsules must be swallowed whole. Healthcare providers and caregivers should handle the medication with caution; direct contact with the powder inside the capsule should be avoided. Clinical Side Effects & Safety Monitoring eratogenicity (Birth Defects): This is the most critical risk. Thalidomide must never be used by pregnant women. Male and female patients must strictly adhere to specialized Risk Evaluation and Mitigation Strategies (REMS). Peripheral Neuropathy: Potential for tingling, numbness, or pain in the hands and feet. Early detection is vital to prevent permanent nerve damage. Venous Thromboembolism (VTE): Increased risk of blood clots (DVT or Pulmonary Embolism), especially when combined with steroids. Prophylactic blood thinners are often prescribed. Drowsiness & Sedation: Patients are advised to avoid heavy machinery or driving until their reaction to the drug is known. Why Source Thalidomide 100mg from Ernest Oncology? Verified Authenticity: Direct sourcing of high-integrity Thalidomide with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Lynide 5mg Capsule (Lenalidomide): Precision Immunomodulatory Therapy for Oncology Care Lynide 5mg Capsule is a high-efficacy oral antineoplastic and immunomodulatory medication containing the active pharmaceutical ingredient Lenalidomide. Manufactured by Glenmark Pharmaceuticals, a globally recognized leader in high-quality medicine, Lynide belongs to the class of drugs known as Immunomodulatory Imide Drugs (IMiDs). The 5mg strength is a vital dosage form used extensively for maintenance therapy, precise dose titration, and the management of chronic hematological malignancies. Therapeutic Indications and Clinical Usage Lynide 5mg is integrated into international oncology protocols for the management of several complex conditions: Multiple Myeloma (MM) Maintenance: Used as a long-term strategy following an autologous stem cell transplant (ASCT) to prolong progression-free survival and prevent disease relapse. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies. Follicular Lymphoma (FL): Administered in combination with rituximab for previously treated adult patients with follicular or marginal zone lymphoma. Mechanism of Action: How Lynide 5mg Works Lynide exerts a multi-pathway biological effect to combat malignant cells while enhancing the body's natural defenses: Cereblon Binding: It binds to the protein Cereblon, part of the E3 ubiquitin ligase complex. This leads to the targeted degradation of essential transcription factors that malignant cells rely on for survival. Immune System Activation: It stimulates the proliferation and activity of T-cells and Natural Killer (NK) cells, significantly increasing the body's innate ability to identify and eliminate tumor cells. Anti-Angiogenesis: It inhibits the development of new blood vessels (angiogenesis) that tumors require for oxygen and nutrient supply. Cytokine Regulation: It suppresses the production of pro-inflammatory cytokines such as TNF-α and IL-6, which are known to promote the growth of myeloma cells in the bone marrow microenvironment. Dosage and Administration Guidelines Administration: Lynide 5 mg is an oral medication. Capsules must be swallowed whole with water. Do not open, crush, or chew the capsules. Consistency: It should be taken at approximately the same time each day, with or without food. Cycle-Based Therapy: In many maintenance protocols, it is taken daily on a 21-day or 28-day cycle. Always adhere to the specific regimen prescribed by your hematologist-oncologist. Dose Flexibility: The 5 mg strength allows clinicians to precisely adjust the dose to manage hematological toxicities or accommodate renal impairment. Safety Profile and Clinical Monitoring Due to its potent biological activity, Lynide 5 mg requires vigilant medical oversight: Hematological Monitoring: Regular Complete Blood Counts (CBC) are mandatory to monitor for neutropenia (low white blood cells) and thrombocytopenia (low platelets). Thromboembolism Risk: Lenalidomide increases the risk of blood clots. Prophylactic anticoagulation (e.g., Aspirin) is frequently prescribed concurrently. Embryo-Fetal Toxicity (REMS): Lenalidomide is a known teratogen. Strict adherence to pregnancy prevention programs is mandatory for all patients, regardless of gender or age. Common Side Effects: These may include fatigue, diarrhea, muscle cramps, skin rashes, and nausea. Storage and Global Handling Instructions Temperature: Store at room temperature (20°C to 25°C). Original Packaging: Keep capsules in the original blister pack to protect them from moisture and light. Safety: Caregivers should avoid direct skin contact with the medication; if a capsule is broken, wash the area immediately with soap and water. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Mitant 12.5mg Capsule (Sunitinib): Targeted Multi-Kinase Inhibition for Advanced Oncology Mitant 12.5 mg Capsule is a high-potency oral therapeutic agent containing the active substance Sunitinib. Classified as a multi-targeted receptor tyrosine kinase (RTK) inhibitor, Mitant is a cornerstone in modern targeted cancer therapy. Manufactured by Intas Pharmaceuticals Ltd., a global leader in high-quality oncology generics, it is designed to interfere with the growth and spread of cancer cells by blocking specific signaling pathways that promote tumor angiogenesis (blood vessel formation) and cellular proliferation. Therapeutic Indications and Clinical Usage Mitant 12.5 mg is utilized globally in advanced oncology protocols for several aggressive malignancies: Renal Cell Carcinoma (RCC): Indicated for the treatment of advanced or metastatic kidney cancer, often serving as a primary first-line therapy. Gastrointestinal Stromal Tumor (GIST): Used for patients whose disease has progressed or who are intolerant to imatinib mesylate. Pancreatic Neuroendocrine Tumors (pNET): Specifically for progressive, well-differentiated pNET in patients with unresectable locally advanced or metastatic disease. Adjuvant Treatment: In specific high-risk clinical scenarios, it is used to reduce the risk of cancer returning after kidney surgery (nephrectomy). Mechanism of Action: How Mitant 12.5mg Works Anti-Angiogenesis: It inhibits receptors for Vascular Endothelial Growth Factor (VEGFR) and Platelet-Derived Growth Factor (PDGFR). By blocking these, it effectively “starves“ the tumor by preventing the development of the new blood vessels it needs to grow. Proliferation Blockade: It targets various other receptor tyrosine kinases (such as KIT and FLT3) that drive the rapid, uncontrolled division of malignant cells. Metastasis Inhibition: By disrupting these vital signaling pathways, Mitant helps limit the cancer's ability to invade surrounding tissues or migrate to distant organs. Dosage and Administration Guidelines Administration: Mitant 12.5 mg is an oral medication. Capsules must be swallowed whole with water; do not crush or chew. Standard Regimen (RCC/GIST): Typically involves a cycle of 4 weeks on treatment followed by 2 weeks off (the 4/2 schedule). Continuous Regimen (pNET): Often prescribed as a continuous daily dose without a rest period. Flexibility: The 12.5 mg strength allows for precise dose titration (e.g., reaching 25 mg, 37.5 mg, or 50 mg) based on the patient’s clinical response and tolerance levels. Food Interaction: It can be taken with or without food but should be taken at a consistent time each day to maintain steady-state plasma concentrations. Safety Profile and Clinical Monitoring Treatment with Mitant 12.5 mg requires vigilant medical oversight for: Cardiovascular Monitoring: Regular blood pressure checks are essential, as Sunitinib can cause hypertension. Hematological Vigilance: Periodic Complete Blood Counts (CBC) are necessary to monitor for neutropenia or thrombocytopenia. Thyroid Function: Monitoring for hypothyroidism is required, as this is a common side effect of TKI therapy. Liver & Heart Health: Periodic blood tests to check liver enzymes and heart function (LVEF) are standard during treatment. Skin Changes: Patients may experience skin discoloration (yellowing) or hair depigmentation during the treatment cycle. Storage and Handling Instructions Temperature: Store at controlled room temperature, 20°C to 25°C. Protection: Keep capsules in their original container to protect them from moisture and light. Safety: Ensure the medication is kept out of reach of children and handled only by the patient or a trained caregiver. Why Choose Ernest Oncology? Ernest Oncology, a Group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India 📞 Order & Inquiry Details [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 https://wa.me/919359902383

Pomalid 4mg Capsules: Targeted Therapy for Multiple Myeloma Description: Discover essential information on Pomalid 4mg capsules. Learn about its use in multiple myeloma, administration, safety protocols, and how to source high-quality oncology medications through Ernest Oncology. Headline: Pomalid 4mg Capsules: Clinical Insights and Patient Safety Guidelines Understanding Pomalid 4mg Capsules Pomalid 4mg capsules are a specialized immunomodulatory medication primarily indicated for the treatment of Multiple Myeloma, a cancer of the plasma cells in the bone marrow. This therapy is often prescribed in combination with other agents, such as dexamethasone, to help manage the disease by targeting abnormal cells and supporting the body’s natural immune response. 1. Clinical Indications & Usage Pomalid is indicated for patients who have previously received other standard treatments for multiple myeloma, including lenalidomide and a proteasome inhibitor, and whose disease has demonstrated progression during or within 60 days of completing the last therapy. It is an oral medication designed to stabilize the condition and extend progression-free survival. 2. Mechanism of Action Targeted Degradation: It binds to the cereblon (CRBN) protein, triggering the ubiquitination and degradation of specific transcription factors (Ikaros and Aiolos) essential for myeloma cell survival. Immune System Activation: It enhances the proliferation and activation of T-cells and Natural Killer (NK) cells to better identify and eliminate malignant cells. Anti-Angiogenic Activity: It inhibits the formation of new blood vessels that provide the necessary nutrients and oxygen for tumor growth. Induction of Apoptosis: It initiates programmed cell death within myeloma cells and disrupts the protective interactions between these cells and the bone marrow microenvironment. 3. Administration and Dosing Guide Dosage: The standard dose is 4 mg taken orally once daily. Cycle: It is typically administered on Days 1 to 21 of each 28-day cycle. Instructions: Capsules should be swallowed whole with water. They may be taken with or without food but should be taken at the same time each day to maintain consistent blood levels. Missed Doses: If a dose is missed, patients should not take two doses at once; they should wait until their next scheduled time. ⚠️ Safety, Side Effects, and Monitoring Common Side Effects: Fatigue, nausea, diarrhea, constipation, back pain, and decreased appetite. Blood Cell Impacts: Pomalid may lower white blood cell, red blood cell, and platelet counts, increasing the risk of infections, anemia, and bruising. Regular blood counts are essential. Severe Risks: It carries significant risks for fetal harm; therefore, strict pregnancy prevention programs must be followed by both men and women. There is also a risk of blood clots (venous thromboembolism). Monitoring: Regular medical check-ups, blood tests (for blood count and liver/kidney function), and monitoring for signs of infection or respiratory issues are vital. 📦 Storage and Handling Specifications Temperature: Store at controlled room temperature (typically 20°C to 25°C). Safety: Keep out of reach of children and pets. Store in a secure, dry place. Handling: Because the drug can be absorbed through the skin, capsules should not be opened, crushed, or broken. If a capsule is damaged, avoid inhaling the powder and wash the area thoroughly with soap and water. 📄 Regulatory and Compliance Documentation GMP Certification International Standards Import Compliance Pharmacovigilance WHY CHOOSE ERNEST ONCOLOGY? Global Reliability Quality Assurance Dedicated Logistics PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Pomalidomide is a prescription medication that must only be used under the strict supervision of a qualified oncologist or healthcare professional. Always consult your doctor before starting any new medication. Use of this drug requires adherence to a mandatory pregnancy prevention program. Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 25mg Capsules: Understanding Targeted Therapy for Oncology Description: Explore key information on Lenalid 25 mg capsules, including clinical indications, dosing, safety, and supply options. Learn how Ernest Oncology supports global access to essential cancer treatments. Lenalid 25mg Capsules: Comprehensive Patient Information and Treatment Guidance Product Profile: Understanding Lenalid 25mg Capsules Lenalid 25mg (Lenalidomide) is a potent immunomodulatory medication utilized primarily in the management of specific hematological malignancies. It acts as both a targeted therapy and an immune-system modulator to assist the body in identifying and controlling abnormal cell growth. 1. Clinical Indications & Usage Multiple Myeloma: Often used in combination with dexamethasone for adult patients and as maintenance therapy following a stem cell transplant. Mantle Cell Lymphoma (MCL): Indicated for patients who have relapsed or progressed after previous therapies. Myelodysplastic Syndromes (MDS): Used for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Lymphoma variants: Used in combination therapy for previously treated Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL). 2. Mechanism of Action Ubiquitin Ligase Modulation: Binds to the CRBN protein, modulating the substrate specificity of the E3 ubiquitin ligase complex. Targeted Degradation: Triggers the proteasomal degradation of specific transcription factors (IKZF1 and IKZF3) critical for the survival of malignant plasma cells. Angiogenesis Inhibition: Blocks the development of new blood vessels that tumors require to grow and spread. Immune Activation: Enhances the body’s natural immune response by stimulating T-cells and Natural Killer (NK) cells to target and destroy cancer cells. 3. Administration and Dosing Guide Routine: Capsules are taken orally once daily, ideally at the same time each day, with a full glass of water. Food Intake: Can be taken with or without food. Handling: Capsules must be swallowed whole. Do not break, crush, chew, or open them. Consistency: Follow your physician’s specific cycle instructions (e.g., Days 1–21 of a 28-day cycle) precisely. ⚠️ Safety, Side Effects, and Monitoring Severe Risks: Significant risk of embryo-fetal toxicity (severe birth defects). Strict adherence to pregnancy prevention programs is mandatory. Hematologic Effects: Can cause significant neutropenia (low white blood cells) and thrombocytopenia (low platelets). Frequent blood tests are required to monitor blood counts. Common Reactions: Fatigue, diarrhea, constipation, rash, muscle cramps, and respiratory infections are frequently reported. 📦 Storage and Handling Specifications Environment: Store at controlled room temperature (20°C to 25°C). Keep in a dry, secure place away from heat, light, and moisture. Security: Keep strictly out of reach of children. Handling Precautions: If a capsule is damaged, avoid inhaling the powder. Wash hands thoroughly after any potential contact. Safe Disposal: Never share medication. Dispose of unused capsules according to local medical waste regulations or consult your pharmacist. 📄 Regulatory and Compliance Documentation Quality Certification: All products sourced from facilities adhering to strict WHO-GMP and international pharmaceutical quality standards. Batch Integrity: Each batch is subjected to comprehensive testing to confirm purity, potency, and stability before export. Documentation Support: Comprehensive documentation (COA, MOA, and regulatory dossiers) is provided to facilitate smooth customs and import compliance. WHY CHOOSE ERNEST ONCOLOGY? Global Supply Expertise Commitment to Quality Customer-Centric Service PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-risk prescription medication that must be used strictly under the guidance of a licensed oncologist or healthcare professional. It is associated with severe birth defects and requires strict adherence to mandatory safety and pregnancy prevention programs. Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 15mg Capsules: Clinical Insights and Patient Safety Guidelines Description: Discover essential information on Lenalid 15 mg capsules for the treatment of multiple myeloma and lymphoma. Learn about its mechanism, administration, and how to source high-quality oncology medications via Ernest Oncology. Lenalid 15mg Capsules: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Lenalid 15mg Capsules Lenalid 15mg (Lenalidomide) is a specialized immunomodulatory medication indicated for the management of various hematological malignancies. It acts by modulating the immune system and inhibiting processes that allow cancer cells to proliferate, making it a cornerstone treatment for patients battling multiple myeloma, myelodysplastic syndromes (MDS), and specific types of lymphoma. 1. Clinical Indications & Usage Multiple Myeloma: Often used in combination with other therapeutic agents to stabilize the disease and support patient recovery. Myelodysplastic Syndromes (MDS): Specifically indicated for patients with transfusion-dependent anemia associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used for patients who have relapsed or progressed after previous standard treatment lines. Follicular and Marginal Zone Lymphoma: Utilized in combination regimens to improve outcomes in previously treated patients. 2. Mechanism of Action E3 Ubiquitin Ligase Modulation: Binds to the CRBN protein, altering the substrate specificity of the E3 ubiquitin ligase complex. Proteasomal Degradation: Triggers the rapid degradation of key transcription factors (IKZF1 and IKZF3) necessary for malignant cell survival. Angiogenesis Inhibition: Suppresses the development of new blood vessels that provide essential nutrients to tumor growths. 3. Administration and Dosing Guide Consistency: Take your capsule at the same time every day to maintain steady blood levels. Intake: Swallow the capsule whole with a full glass of water. Do not crush, chew, or open the capsule, as the contents can be harmful if they touch the skin. Flexibility: It can be taken with or without food. Cycle Adherence: Follow the exact cycle schedule (e.g., Days 1–21 of a 28-day cycle) as prescribed by your oncologist. If you miss a dose, consult your healthcare provider rather than taking an extra capsule. ⚠️ Safety, Side Effects, and Monitoring Pregnancy Warning: This medication is structurally related to thalidomide and can cause severe, life-threatening birth defects. A strict pregnancy prevention program is mandatory. Blood Cell Monitoring: Lenalidomide can lower blood cell counts, increasing the risk of infection, anemia, or bruising. Regular complete blood count (CBC) tests are essential. Common Side Effects: Fatigue, diarrhea, rash, and muscle cramps are common. Report any persistent or severe symptoms, such as fever or dizziness, to your medical team. 📦 Storage and Handling Specifications Storage: Keep at a controlled room temperature (20°C to 25°C) in a dry, dark place. Security: Store in a secure location completely out of the reach of children and pets. Handling: Direct contact with the capsule powder must be avoided. If a capsule is damaged, avoid inhaling the powder and wash affected skin areas thoroughly with soap and water. Disposal: Do not share this medicine. Return any unused capsules to your pharmacy or dispose of them according to local hazardous medical waste protocols. 📄 Regulatory and Compliance Documentation GMP Certified: All medications are sourced from facilities that strictly adhere to World Health Organization Good Manufacturing Practices. Comprehensive Documentation: Every shipment is accompanied by a Certificate of Analysis (COA) and Method of Analysis (MOA) to verify purity and potency. Export Verification: Our processes include all necessary regulatory documentation required for health authority clearance in the USA, UK, Australia, and South Africa. WHY CHOOSE ERNEST ONCOLOGY? Global Logistics Excellence Uncompromising Quality Control Dedicated Patient-First Support PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-potency prescription drug that must only be used under the supervision of a qualified oncologist. It is strictly contraindicated in pregnancy due to the risk of severe birth defects. Always consult with your healthcare provider for diagnosis and treatment. Contact Ernest Oncology — Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

Lenalid 10mg Capsules: Clinical Insights and Patient Safety Guidelines Description: Discover essential information on Lenalid 10mg capsules for the treatment of multiple myeloma and lymphoma. Learn about its mechanism, administration, and how to source high-quality oncology medications via Ernest Oncology. Lenalid 10mg Capsules: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Lenalid 10mg Capsules Lenalid 10mg (Lenalidomide) is a targeted immunomodulatory therapy used to treat various blood cancers. By modulating the immune system and disrupting the pathways that cancer cells use to survive and multiply, it serves as a fundamental medication for patients diagnosed with specific hematological conditions. 1. Clinical Indications & Usage Multiple Myeloma (MM): Used as maintenance therapy following an autologous hematopoietic stem cell transplant (auto-HSCT). Myelodysplastic Syndromes (MDS): Indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality. Mantle Cell Lymphoma (MCL): Used for patients whose disease has relapsed or progressed after prior therapies. Follicular and Marginal Zone Lymphoma: Used in combination with other treatments for patients who have received at least one prior systemic therapy. 2. Mechanism of Action E3 Ubiquitin Ligase Binding: Binds to the Cereblon (CRBN) protein to modulate the substrate specificity of the CRL4-CRBN E3 ubiquitin ligase complex. Angiogenesis Inhibition: Suppresses the production of vascular endothelial growth factor (VEGF), effectively starving tumors of their necessary blood supply. Immune System Activation: Stimulates the activation and proliferation of T-cells and natural killer (NK) cells to enhance anti-tumor immune responses. 3. Administration and Dosing Guide Consistency: Take the capsule orally once daily, ideally at the same time every day, to maintain consistent blood levels. Intake: Swallow the capsule whole with a full glass of water. Do not crush, break, chew, or open the capsule. Cycle Adherence: Follow the exact dosing schedule provided by your oncologist (e.g., continuous daily use or specific cycles such as Days 1–21 of a 28-day cycle). Missed Doses: If a dose is missed, do not take an extra capsule. Resume your regular schedule the following day. ⚠️ Safety, Side Effects, and Monitoring Pregnancy Warning: Lenalidomide can cause severe, life-threatening birth defects. Patients must strictly adhere to mandated pregnancy prevention programs. Blood Cell Impacts: This medication can cause neutropenia (low white blood cells) and thrombocytopenia (low platelets). Frequent monitoring via blood tests is essential. Common Side Effects: Fatigue, diarrhea, rash, and muscle cramps are common. Report any persistent or severe symptoms to your medical team. 📦 Storage and Handling Specifications Storage: Store in a secure, dry place at controlled room temperature (20°C to 25°C). Security: Keep strictly out of reach of children and pets. Handling Precautions: Avoid direct skin contact with the capsule contents. If a capsule is damaged, avoid inhaling the powder and wash affected areas thoroughly with soap and water. Disposal: Do not share this medication. Return unused capsules to your pharmacist or follow local medical waste disposal protocols. 📄 Regulatory and Compliance Documentation GMP Certified Pharmacopoeia Standards Export Documentation Global Compliance WHY CHOOSE ERNEST ONCOLOGY? Global Supply Reliability Quality Assurance Dedicated Support PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Lenalidomide is a high-potency prescription medication that must be used strictly under the guidance of a licensed oncologist. It is contraindicated in pregnancy and requires adherence to strict safety programs. Always consult your physician for diagnosis and treatment. 📞 Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383